-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: ARUK: Alzheimer’s Research UK
Digital Technology for Early Detection of Neurodegenerative Disease (BBC News / EDoN)
Summary The Early Detection of Neurodegenerative Diseases (EDoN) initiative, with backing from Alzheimer’s Research UK, is working to develop wearable devices which will collect data to help detect the early stages of Alzheimer’s Disease and other neurodegenerative diseases. Full Text … Continue reading →
Posted in Alzheimer’s Research UK, BBC News, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Parkinson's Disease, Quick Insights, UK, Universal Interest
|
Tagged Accelerating Detection of Disease Programme, Alan Turing Institute, Alzheimer's Disease: Diagnosis, Alzheimer’s Disease, Alzheimer’s Research UK (ARUK), Artificial Intelligence (AI), ARUK: Alzheimer’s Research UK, Asymptomatic Alzheimer’s Disease, Automatic Speech Analysis, BBC Health News, BBC Technology News, Behavioural Biomarkers, Benefits of Early Detection, Big Data, Bill and Melinda Gates Foundation, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, CrawfordWorks, David Cameron, David Cameron: Former Prime Minister, Digital Biomarkers, Digital Diagnostic Tools, Digital Fingerprints, Digital Technology, Digital Technology and Innovation, Early Detection of Alzheimer’s Disease, Early Detection of Disease, Early Detection of Neurodegenerative Diseases, Early Detection of Neurodegenerative Diseases (EDoN), Early Detection of Preclinical Disease, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Diagnosis of Dementia, Early Recognition of Alzheimer’s Disease Using Digital Technology, Early Recognition of Neurodegenerative Diseases Using Digital Technology, EDoN Clinical Support Group, EDoN Cohorts and Biomarkers Working Group, EDoN Digital Platform Working Group, EDoN Digital Support Group, EDoN Digital Toolkit, EDoN Digital Tools Working Group, EDoN Fingerprint Analytics Working Group, EDoN White Paper, Ethical Considerations, Ethical Sharing of Data Between Organisations, Fingerprint Analytics, Gait: an Integrative Measure of Health, Heart Rate, Iceland Foods Charitable Foundation, Information Technology, International and Independent External Advisory Board, Investment in Information Technology, Machine Learning Models, Medopad, Mild Cognitive Impairment (MCI), Mindstrong Health, MRC Harwell Institute, National Hospital for Neurology and Neurosurgery: University College London, National Physical Laboratory, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Newcastle University, Non-Invasive Biomarkers, Optimising Benefits of Digital Technology, Preclinical Alzheimer's Disease, Preclinical Biomarkers and Dementia, Preclinical Biomarkers in Alzheimer's Disease, Preclinical Dementia and Associated Lifestyle Changes, Preclinical Indicators and Dementia, Preclinical Indicators in Alzheimer's Disease, Preclinical Phase of Dementia, Prodromal Alzheimer's Disease, Prodromal Dementia, Rates of Conversion From Mild Cognitive Impairment to Dementia, Research Informatics, Sleep Patterns, Smart Phone apps, Smart Sensors, Smart Watches, Target Discovery and Preclinical Validation, Tencent, The Rt Hon David Cameron: Chair of EDoN Board, The Rt Hon David Cameron: President of Alzheimer’s Research UK, Timely / Preclinical Neurodegenerative Diseases Diagnosis, Timely Screening / Preclinical Neurodegenerative Disease, University College London, University of Cambridge, University of Exeter, University of Oxford Big Data Institute, Walking Speed: a Behavioural Biomarker for Neurocognitive and Physical Decline, Wearable Devices, Wearable Monitoring Equipment, Wearable Sensors, Wearable Technology, Wearables (Technology)
|
Leave a comment
Further Brief Insights Into the Potentially Neuroprotective Benefits of Certain Foods (BBC News / Scientific Reports / ARUK / AAIC)
Summary There is evidence to suggest that the protein β-parvalbumin found in fish inhibits the formation of α-synuclein (the protein present in Parkinson’s Disease). The cross-reaction of β-parvalbumin and human amyloidogenic proteins may explain at least some of the health … Continue reading →
Posted in Alzheimer’s Research UK, Charitable Bodies, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Nutrition, Parkinson's Disease, Quick Insights, Statistics, UK, Universal Interest
|
Tagged 2017 Alzheimer’s Association International Conference (AAIC®2017), Abnormal Proteins (Alpha-Synuclein), Alpha-Synucleinopathies, Alzheimer's and Dementia: The Journal of the Alzheimer's Association, Alzheimer’s Association, Alzheimer’s Association AAIC Press Office, Alzheimer’s Association International Conference (AAIC®2017), Alzheimer’s Research UK (ARUK), Amyloidogenic Proteins, Anti-Inflammatory (Foods), Antioxidants, ARUK: Alzheimer’s Research UK, Baltic Sea Diet, Berries, Beta-Carotene, Beta-Parvalbumin, Blueberries, BSD (Baltic Sea Diet), Chalmers University of Technology, Cognitive Performance in Older US Adults: Health and Retirement Study, Columbia University, CoSTREAM Project: EU's Horizon 2020 Research and Innovation Programme, DASH (Dietary Approaches to Stop Hypertension), Dementia Prevention, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Department of Biology and Biological Engineering: Chalmers University of Technology, Diet, Diet and Dementia, Dietary Approaches to Stop Hypertension (DASH) Diets, Dietary Behaviour, Dietary Factors, Dietetic Input, Dr David Reynolds: Alzheimer's Research UK, Eating Leafy Greens, Environmental Risk Factors, Epidemiology, Epidemiology and Statistics, Fish, Fish Consumption, Flavonoids, Health and Retirement Study (HRS), Health and Retirement Study (US), Healthy Behaviours, Healthy Eating, Healthy Lifestyles, Healthy Living, Healthy Nordic Diet, HRS: Health and Retirement Study, Inflammation-Related Nutrient Pattern (INP), Inflammatory Nutrient Pattern Associated With Cognitive Brain Ageing, α-Synuclein, α-Synuclein Misfolds, β-Parvalbumin, Karolinska Institute, Karolinska Institutet, Leafy Greens, Lifestyle Risk Factors, Mediterranean and DASH (Dietary Approaches to Stop Hypertension) Diets, Mediterranean Diet, Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND Diets), Modifiable Risk Factors, National Institutes of Health / National Institutes on Aging, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neuroprotection, Neuroprotection Research, Neuroprotective Agents, Neuroprotective Dietary Patterns Associated With Better Cognitive Performance, Neuroprotective Diets, Neuroprotective Lifestyles, Nordic Prudent Diet Reduces Risk of Cognitive Decline, Nordic Prudent Dietary Pattern (NPDP), Parkinson’s Disease Pathogenesis, Poor Diet Linked to Inflammation, Prevention, Prevention Agenda, Prevention of Dementia, Prevention of Parkinson’s Disease, Sweden, Synucleinopathy, The Health and Retirement Study, US National Institute on Aging, Wake Forest School of Medicine in Winston-Salem (North Carolina), Women Who Eat Well Less Likely to Develop Dementia, Women’s Health Initiative Memory Study (WHIMS)
|
Leave a comment
Diagnosis of Primary Progressive Aphasia (JGCR / Journal of Neurology / ARUK / BBC News)
A Journal of Geriatric Care and Research (JGCR) case report discusses the neuropsychological assessments preparatory to the differential diagnosis of Primary Progressive Aphasia (PPA). PPA is a rare form of non-Alzheimer’s dementia featuring language impairment with progressive decline in word … Continue reading →
Posted in Alzheimer’s Research UK, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Local Interest, Mental Health, Models of Dementia Care, Patient Information, Person-Centred Care, Quick Insights, UK
|
Tagged Alzheimer’s Research UK (ARUK), Aphasia, ARUK: Alzheimer’s Research UK, Assessment and Diagnosis, BBC Health News, Canonical Syndromes of Primary Progressive Aphasia: Logopenic Variant (lvPPA), Canonical Syndromes of Primary Progressive Aphasia: Non-Fluent / Agrammatic Variant (nfvPPA), Canonical Syndromes of Primary Progressive Aphasia: Semantic Variant (svPPA), Communication and Language Impairment, Degenerative Jargon Aphasia, Delis Kaplan Executive Function System (DKEFS), Dementia Research Centre: University College London, Department of Neurodegenerative Disease: University College London, Differential Diagnosis, Division of Psychology and Language Sciences: University College London, Early Diagnosis, Faculty of Health and Social Care: University of Chester, Frontotemporal Lobar Degeneration (FTLD), Journal of Geriatric Care and Research (JGCR), Journal of Neurology, Keele University, Linguistic Impairments, Logopenic Aphasia, Logopenic Progressive Aphasia, Misdiagnosis (Potential), Neologistic Jargon Aphasia, Neurodegeneration, Neurodegenerative Diseases, Neurodegenerative Disorders, Neuropsychological Assessment, Non-Fluent Variant Primary Progressive Aphasia, Primary Progressive Aphasia (PPA), Rare Neurodegenerative Conditions, Research Institute for Primary Care and Health Sciences: Keele University, Semantic Variant Primary Progressive Aphasia, South Staffordshire and Shropshire Healthcare NHS Foundation Trust, Temporal Lobe Atrophy, Timely Diagnosis, UCL Institute of Neurology: University College London, University College London, University of California, University of Chester, Variants of Primary Progressive Aphasia (PPA)
|
Leave a comment
David Cameron on Need for Increasing Dementia Research Funding (BBC News)
Summary David Cameron, the former Prime Minister, has taken-up the role of President of Alzheimer’s Research UK (in addition to working for the National Citizen Service). He has proposed / re-stated the importance of greater levels of funding for dementia … Continue reading →
Posted in Alzheimer’s Research UK, BBC News, Commissioning, In the News, Management of Condition, Mental Health, National, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, UK, Universal Interest
|
Tagged Alzheimer's Research UK, Alzheimer’s Research UK (ARUK), ARUK: Alzheimer’s Research UK, BBC Health News, BBC Politics News, Challenge on Dementia (David Cameron), Challenge on Dementia 2020, David Cameron, David Cameron: Former Prime Minister, David Cameron: President of Alzheimer's Research UK, Defeat Dementia Campaign, Defeat Dementia Campaign (Alzheimer’s Research UK), Dementia Awareness, Dementia Awareness Raising, Dementia Research, Dementia Research Funding, Dementia Risk Prevention, Dementia Risk Reduction and Prevention, Dementia-Friendly Communities, Dementia-Friendly Environments, Investment in Dementia Prevention, National Citizen Service, National Citizen Service in England and Northern Ireland, Prevention Agenda, Prime Minister's Challenge on Dementia, Prime Minister’s Challenge On Dementia 2020, The Rt Hon David Cameron: President of Alzheimer’s Research UK
|
Leave a comment
Lost and All At Sea: Game-Players Feed Dementia Research? (BBC News / Neuroscience 2016 Conference / Alzheimer’s Research UK / JGCR / Brain)
Summary Researchers at University College London have used a popular video game called Sea Hero Quest to investigate how players’ sense of direction and navigational ability typically decline over a lifetime. Analysis of the results could help dementia researchers develop … Continue reading →
Posted in Alzheimer’s Research UK, BBC News, Charitable Bodies, Diagnosis, For Researchers (mostly), In the News, International, Quick Insights, UK, Universal Interest
|
Tagged Alzheimer’s Research UK (ARUK), APOE e4 Carriers, ARUK: Alzheimer’s Research UK, At-Genetic-Risk Alzheimer's Disease, BBC Health News, Behavioural Biomarkers, Big Data, Bournemouth University, Brain (Journal), Christoph Hölscher: ETH Zurich, Computer Games, Cross-Sector Collaboration, Decline in Navigational Ability, Dementia, Dementia Research, Denmark, Department of Clinical Educational and Health Psychology: University College London, Department of Clinical Neurosciences: University of Cambridge, Department of Electrical Engineering: University College London, Department of Psychiatry: University of Cambridge, Deutsche Telekom, Deutsche Telekom’s Sea Hero Quest Project, Diagnosis, Differential Diagnosis, Digital Diagnostic Tools, Disorientation, Dr David Reynolds: Alzheimer's Research UK, Dr Hugo Spiers: UCL Institute of Behavioural Neuroscience, Dr. Axel Wehmeier: Managing Director of Telekom Healthcare Solutions, Ed Manley: University College London, ETH Zurich, Finland, Gamification, Glitchers, Global Benchmark of Human Spatial Navigation, Hilary Evans: Chief Executive of Alzheimer’s Research UK, HTC Vive iVR Equipment, Human Spatial Navigation, Information Technology, Institute of Cognitive Neuroscience: University College London, Jan Weiner: Bournemouth University, Journal of Geriatric Care and Research (JGCR), Loss of Sense of Direction, McGill University, Michael Hornberger: University of East Anglia, MRC Cognition and Brain Sciences Unit: University of Cambridge, Multisectoral Collaboration, Navigational Ability, Neurodegenerative Diseases, Neuroscience 2016 Conference, Non-Invasive Biomarkers, Nordic Countries (Superior Navigational Skills), Nordic Nations, Nordic Regions, Northumbria University, Norway, Prof Christophe Hoelscher: Chairman of Cognitive Science at ETH Zurich, Ricardo Silva: University College London, Ruth Dalton: Northumbria University, Saber Sami: University of Cambridge, Sea Hero Quest (SHQ) Game, Sea Hero Quest VR, Sense of Direction, Sexual Inequalities, Social Inequality, Socio-Cultural Inequalities, Socio-Political Inequalities, Spatial Disorientation, Spatial Navigation Benchmarks, Spatial Navigation Tests of Disorientation, Spiers Lab, Sweden, UCL Spatial Cognition Group, University College London, University College London (UCL), University of Cambridge, University of East Anglia, Veronique Bohbot: McGill University, Viking Blood, Virtual Reality, World Economic Forum's Gender Gap Index
|
Leave a comment
Dementia 2020 Citizens’ Engagement Programme Toolkit (Department of Health)
Summary A new toolkit, aimed at dementia groups and networks, offers guidance and advice on facilitating conversations with persons affected by dementia and their carers concerning the Government’s work on dementia. An online survey, open to persons (and their families … Continue reading →
Posted in Alzheimer's Society, Alzheimer’s Research UK, Charitable Bodies, Commissioning, Community Care, Department of Health, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Patient Care Pathway, Patient Information, Person-Centred Care, Quick Insights, Standards, UK, Universal Interest
|
Tagged Active Engagement, Advisory Group for Dementia 2020 Citizens' Engagement Programme (Department of Health), Ageing and Disability Division (Department of Health), Alzheimer Experience, Alzheimer’s Research UK (ARUK), ARUK: Alzheimer’s Research UK, Carer Experience, Carer's Experience of Dementia, Carers’ Experiences of the Dementia Journey, Challenge on Dementia 2020, Citizens' Engagement Programme Toolkit (Dementia 2020), Community Care Group / Social Care (Department of Health), Community Engagement, Consent to Share Information, DEEP Guide: Collecting the Views of People With Dementia, DEEP Guides, DEEP Guides: Supporting Involvement of People With Dementia, DEEP2: Dementia Engagement and Empowerment Project, DEEP: Dementia Engagement and Empowerment Project, Dementia 2020 Citizens' Engagement Programme, Dementia 2020 Citizens' Engagement Programme: Group Discussion Template, Dementia 2020 Citizens' Engagement Programme: Template for Feedback, Dementia 2020 Citizens' Engagement Programme: Toolkit, Dementia and Disabilities Branch (Department of Health), Dementia Engagement and Empowerment Project (DEEP), Dementia Experiences, Dementia Groups, Dementia Networks, Dementia Words Matter: Guideline, Dementia-Friendly Meeting Spaces, Department of Health Consultation Regarding UK Government’s Work on Dementia, Department of Health: Dementia Policy Team, Department of Health’s Advisory Group for the Dementia 2020 Citizens' Engagement Programme, Disclosing Information and Consent, Embedding Patient Experience in Service Delivery, Embedding Patient Experience in Service Design, Engagement, Engagement and Co-Production, Engagement Facilitation: DEEP Recommendations on Facilitating Focus Groups for People With Dementia, Engagement Facilitation: Hints and Tips, Engagement Facilitation: Organising Group Discussions, Engagement Facilitation: Organising One to One Discussions, Engaging With People Having Experience of Dementia, Experience Based Co-Design, Experience Based Design, Experiences of Diagnosis, Experiences of Health Care Services, Experiences of Social Care Services, Experiences of the Transition to Dementia, Experts by Experience, Facilitating Discussions Effectively and Sensitively, Facilitating Focus Groups for People With Dementia (DEEP Recommendations), Family and Caregiver Experiences, Focus Groups, Group Discussions (Focus Groups), iD: Innovations in Dementia, Improving Patient Experience, Improving the Experience of Dementia, Informed Consent, Innovations in Dementia, Innovations in Dementia: a CIC, Patient and Family Engagement, Patient and Public Engagement (PPE), Personal Experience of Dementia, Prime Minister’s Challenge On Dementia 2020, Principles for Engagement, Public Engagement, Public Engagement Exercises, Together in Dementia (tide - Trade Marked Acronym)
|
Leave a comment
Public Awareness of the Risk Factors for Dementia (PHE / NatCen / Alzheimer’s Society)
Summary A survey commissioned by Public Health England (PHE) has identified patchy levels of awareness concerning the “known” dementia risk factors. Most British people, it appears, are able to identify at least one risk factor for increased risk of developing … Continue reading →
Posted in Alzheimer's Society, Alzheimer’s Research UK, Universal Interest
|
Tagged Ageing and Society, Ageing Population, Alzheimer’s Research UK (ARUK), Alzheimer’s Society: Be Head Strong, ARUK: Alzheimer’s Research UK, Attitudes To Dementia (2015 British Social Attitudes Survey): Attitudes to Dementia, Attitudes To Dementia (2015 British Social Attitudes Survey): Dementia-Friendly Communities, Attitudes To Dementia (2015 British Social Attitudes Survey): Experience of Dementia, Attitudes To Dementia (2015 British Social Attitudes Survey): Knowledge of Dementia, Attitudes To Dementia (2015 British Social Attitudes Survey): Seeking Help, Attitudes To Dementia: Findings From 2015 British Social Attitudes Survey, “One You” Campaign, Blackfriars Consensus Statement, British Social Attitudes survey (BSA), Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dementia-Friendly Communities, Depression, Determinants of Health, Diabetes Epidemic, Diseases and Medical Conditions Associated With Dementia Risk, Diseases and Medical Conditions Associated With Increased Dementia Risk: Depression, Diseases and Medical Conditions Associated With Increased Dementia Risk: Down’s Syndrome, Diseases and Medical Conditions Associated With Increased Dementia Risk: High Blood Pressure, Diseases and Medical Conditions Associated With Increased Dementia Risk: Mild Cognitive Impairment (MCI), Diseases and Medical Conditions Associated With Increased Dementia Risk: Parkinson’s Disease, Diseases and Medical Conditions Associated With Increased Dementia Risk: Stroke, Diseases and Medical Conditions Associated With Increased Dementia Risk: Type 2 Diabetes, Down's Syndrome, Dr Charles Alessi: Lead Prevention of Dementia at Public Health England, Dr Matthew Norton: Alzheimer's Research UK, Eatwell Plate, Education and Awareness, Epidemiology, Epidemiology and Statistics, Ethnicity, George McNamara: Head of Policy and Public Affairs at Alzheimer’s Society, Head Injuries and Dementia, Health Determinants, Health Improvement, Health Inequalities, Health Matters: Midlife Approaches to Reduce Dementia Risk, Health Policy, Health Wellbeing and Independence, Health-Creating Society, Healthy Ageing, Healthy Behaviours, Healthy Communities, Healthy Eating, Healthy Lifestyles, Healthy Living, High Blood Pressure, Improving Local Public Health, Improving Public Health, infographics on Dementia Risk Reduction, Interventions to Increase Patient Activation, Investment in Dementia Prevention, Life Course Approach, Life-Course Approach to Healthy and Active Ageing, Lifestyle, Lifestyle Intervention Programmes, Lifestyle Risk Factors, Mild Cognitive Impairment (MCI), Modifiable Risk Factors, NatCen: British Social Attitudes survey (BSA), National Centre for Social Research (NatCen), NHS OneYou, One You Campaign (PHE), Overlapping Risk Factors, Patient Activation, Patient Empowerment, Patient Empowerment Movement, Patient Engagement, Patient Engagement Strategies, Patient Factors (Demand Side), Patient Involvement, Physical Exercise, Prevalence of Type 2 Diabetes, Preventing and Managing Demand, Prevention, Prevention Agenda, Prevention of Dementia, Prevention of Dementia: Public Health England, Prevention Programmes, Preventive Care, Preventive Services, Promoting Brain Health (Blackfriars Consensus Statement), Protective Factors, Public Awareness, Public Awareness of the Risk Factors for Dementia (2016 UK), Public Health, Public Health England (PHE), Public Health Promotion Campaigns, Risk Factors, Self-Care, Self-Determination, Self-Directed Services, Self-Help, Self-Management, Self-Management Programmes, Self-Management Support, Staying Healthy for Longer, Stigma of Dementia, Supporting People to Manage Their Health, Susan Reid: Research Director at NatCen, Type 2 Diabetes
|
Leave a comment
Further Funding for the Dementia Research Institute (Gov UK / MRC / Alzheimer’s Society / ARUK)
Summary Additional partnership funding has been announced for Dementia Research Institute (DRI). The Alzheimer’s Society and Alzheimer’s Research UK have each committed £50 million towards supporting the work of the Institute, making the total commitment to date around £250 million … Continue reading →
Posted in Alzheimer's Society, Alzheimer’s Research UK, Charitable Bodies, Commissioning, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, UK, Universal Interest
|
Tagged Alzheimer’s Research UK (ARUK), Alzheimer’s Research UK’s Drug Discovery Alliance, ARUK: Alzheimer’s Research UK, Challenge on Dementia (David Cameron), Challenge on Dementia 2020, Cross-Sector Partnerships, David Cameron, Dementia Research, Dementia Research Careers, Dementia Research Funding, Dementia Research Institute (DRI), Dementia Research: UK Impact, Dementia Risk Reduction, Department for Business Innovation and Skills, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Discovery Alliance, Drug Discovery Programmes, Global Action Against Dementia, Global Context, Global Dementia Discovery Fund (2015), Global Dementia Research, Global Leadership, Global Outlook, Hilary Evans: Chief Executive of Alzheimer’s Research UK, International Dementia Research, Jeremy Hughes CBE: Chief Executive of the Alzheimer’s Society, Jo Johnson MP, Jo Johnson: Universities and Science Minister, Living Well with Dementia Research, Medical Research Council (MRC), Medical Research Council (UK), MRC: Medical Research Council, Neurodegeneration, Neurodegenerative Disease Research, Partnership and Collaboration, Partnership Working, Prime Minister’s Challenge On Dementia 2020, Promisary Science, Public Health Strategies, Research and Development, Research and Innovation, Research Commitment, Research Funding, Sir John Savill: Chief Executive of the Medical Research Council, UK Dementia Research Institute
|
Leave a comment
Significant Changes at the World Dementia Council? (WDC)
Summary There has been reform within the World Dementia Council (WDC). The changes are intended to make this body “more representative” in global terms (if such were possible) and fully independent. The Council now includes a wider range of international … Continue reading →
Posted in Alzheimer’s Disease International (ADI), Alzheimer’s Research UK, Charitable Bodies, Commissioning, Department of Health, Diagnosis, For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK, Universal Interest, World Health Organization (WHO)
|
Tagged Abuse of Vulnerable Adults, Academia-Industry Partnerships, Academic Research, Alternatives to Antipsychotic Drugs, Alzheimer's Association, Alzheimer’s Disease: Risk Factors, Alzheimer’s Research UK (ARUK), Argentina, ARUK: Alzheimer’s Research UK, Assistive Technology, Associate Members (WDC), Awareness, Awareness Raising, Behavioural Risk Factors, Big Data, Big Data Partnership, Big Pharma, Bill and Melinda Gates Foundation, Biopharmaceutical Companies, Biotechnology, Challenge on Dementia (David Cameron), Charitable Funding, Clinical Trial Efficiencies, Collaboration, Collaborative Projects, Cross-Sector Partnerships, Data Sharing, Dementia Challenge, Dementia Consortium, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Friends, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Research: UK Impact, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dennis Gillings: Former World Dementia Envoy, Department of Health Dementia Challenge, Department of Health’s Integrated Development Initiative, Digital Technology, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dr Yves Joanette: Scientific Director of Canadian Institute of Health Research (Institute of Aging), Emerging Technology, Enabling Technology, Future Long-Term Care Costs, GAAD: Global Action Against Dementia, Global Action Against Dementia, Global Action Against Dementia (GAAD), Global Outlook, Global Social Investment for Dementia, Government Research Funding, Hilary Doxford: World Dementia Council Member, Indonesia, Information Technology, Innovative Technology, International Collaborations, International Dementia Research Inventories, International Programmes, Interventions for Social Isolation and Loneliness in Men, Investment in Technology, Join Dementia Research, Leveraging Big Data, Lifestyle Risk Factors, Loneliness and Social Isolation, Modifiable Risk Factors, National Institute of Ageing (NIA), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurological Research, Nigeria, Open Data and Big Data, Organisation for Economic Co-operation and Development (OECD), Partnership and Collaboration, Partnership Working, Philanthropic Funding, Pipeline Databases, Prevention, Prevention of Dementia, Prime Minister’s Challenge On Dementia 2020, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Raj Long: Vice Chair of World Dementia Council, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Stigma, Regulatory Agencies, Regulatory Experts, Research and Development, Research and Innovation, Research Commitment, Research Funding, Resource and Incentives, Restraint and Restrictions, Restraint in Health and Adult Social Care, Risk Factors, Risk Reduction, Risk Reduction (Formerly Termed Prevention by WDC), Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, Social Isolation, Stigma, Taiwan, Treatment and Prevention of Dementia, US National Institute on Aging, WDC: World Dementia Council, World Dementia Council, World Health Organisation (WHO), Yves Joanette: Chair of World Dementia Council
|
Leave a comment
Repurposing of Existing Drugs to Prevent Dementia? (BBC News / Science Advances /Alzheimer’s Research UK)
Summary A number of drugs, already approved as safe for the treatment of other conditions, and which could help protect against Alzheimer’s Disease, are said to have been detected and short-listed for further investigation. Full Text Link Reference Alzheimer’s preventative … Continue reading →
Posted in Alzheimer's Society, Alzheimer’s Research UK, Animal Studies, BBC News, Charitable Bodies, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, UK, Universal Interest
|
Tagged Ab42 Fibril Formation, Alzheimer's Research UK, Alzheimer’s Research UK (ARUK), Alzheimer’s Research UK Drug Discovery Institute, Amyloid Beta Protein, Amyloid Cascade Hypothesis, Amyloid Hypothesis, Amyloid Proteins, Amyloid-β (Aβ), Amyloid-β Protein, Anti-Amyloid Therapies, ARUK: Alzheimer’s Research UK, ß-amyloid, BBC Health News, Behind the Headlines, Beta-Amyloid, Bexarotene (Elevated Triglycerides), Bexarotene (Targretin), Center for Molecular Protein Science: Lund University, Cleveland Clinic Lou Ruvo Center for Brain Health, Collaborative Drug Discovery Programmes, Conversion to Dementia From Prodromal Disease, Critical Appraisals, Department of Biochemistry and Structural Biology: Lund University, Department of Chemistry: University of Cambridge, Department of Psychology: University of Nevada, Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Discovery Programmes, European Research Institute for the Biology of Aging (Groningen), Fibrillar Deposits (Alzheimer's Disease), Fibrils, β-Amyloid 1-42 (Aβ42), Lund University (Sweden), Microscopic Worms, Netherlands, Neurofibrillary Tangles (NFTs), Neurological Research, Neurostatin (Hypothetical Construct), Off-Label Drug Repurposing Trials, Off-Licence Drugs, Potential Repurposing of Drugs to Slow Progression of Alzheimer’s Disease, Prodromal Alzheimer's Disease, Protein Aggregation, Repurposing of Drugs, RXR Agonists, Science Advances (Journal), Statins for the Brain (Hypothetical Construct), Sweden, University Medical Centre Groningen, University of Cambridge, University of Groningen, University of Nevada, USA, Worms: C. elegans
|
Leave a comment
